Copper-67-Labeled Bombesin Peptide for Targeted Radionuclide Therapy of Prostate Cancer

Copper-67-Labeled Bombesin Peptide for Targeted Radionuclide Therapy of Prostate Cancer

The gastrin-releasing peptide receptor (GRPR) is a promising molecular target for imaging and therapy of prostate cancer using bombesin peptides that bind to the receptor with high affinity. Targeted copper theranostics (TCTs) using copper radionuclides, <sup>64</sup>Cu for imaging and &...

Full description

Bibliographic Details
Main Authors: Truc T. Huynh, Ellen M. van Dam, Sreeja Sreekumar, Cedric Mpoy, Benjamin J. Blyth, Fenella Muntz, Matthew J. Harris, Buck E. Rogers
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Pharmaceuticals
Subjects:
gastrin-releasing peptide receptor
bombesin peptide antagonist
theranostic
copper-67
Online Access:https://www.mdpi.com/1424-8247/15/6/728

Internet

https://www.mdpi.com/1424-8247/15/6/728

Similar Items